BioAsia 2026 in Hyderabad
Analysis based on 16 articles · First reported Feb 05, 2026 · Last updated Feb 08, 2026
The BioAsia 2026 conference is expected to positively impact the life sciences and healthcare markets by fostering collaboration, innovation, and investment, particularly in AI-driven drug discovery and biomanufacturing. The event reinforces Hyderabad's standing as a global hub, potentially attracting further capital and talent to the region and benefiting participating companies like Amgen, Sanofi, and Novartis.
BioAsia 2026, Asia's flagship life sciences and healthcare forum, will convene global leaders in science, artificial intelligence, and industry in Hyderabad, India===Telangana, on February 17-18, 2026. The conference, themed 'TechBio Unleashed: AI, Automation & the Biology Revolution,' will explore how AI-native biology, advanced automation, and digital-first healthcare models are transforming therapy discovery, development, and delivery. India===Telangana Chief Minister Revanth Reddy and IT Minister D. Sridhar Babu will deliver inaugural addresses, emphasizing India===Telangana's ambition to position Hyderabad among the world's top five life sciences hubs. A dedicated 'India===Telangana Rising Vision 2047' session will outline the state's long-term roadmap for innovation-led growth. The event will feature eminent speakers from companies such as Miltenyi Biotec, Amgen, Alphabet Inc.===Google DeepMind, Sanofi, Merck & Co., Novartis, Medtronic, Eli Lilly and Company, and Unilabs, discussing topics from AI-driven discovery to resilient global supply chains.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard